Pune, India -- (SBWire) -- 05/31/2018 --Global Nasal Spray Market is expected to reach USD 19.4 billion by 2024 from USD 11.9 billion in 2016, at a CAGR of 6.3% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-nasal-spray-market
Global Nasal Spray Market, By Type (Decongestant nasal spray, salt water solution/ saline nasal spray, steroid nasal spray), By Container Design (Pressurized Canisters, Pump Bottles), By Dosage form (Unit/Single dose, Bi-dose, multi-dose), By Prescription (Prescribed, Over-the-counter), By Therapeutic Class (Antihistamine, Nasal Steroids, Mast Cell Inhibitor, Anticholinergic), By Application (Allergic and non-allergic Rhinitis, Nasal Congestion, CNS disorders, Vaccination, Others), End User (Hospital, ASC/Clinics, Home Care Setting, Pharmacy, Others), By Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024
Get 10% Discount Instant Mail us @ sopan.gedam@databridgemarketresearch.com
Competitive Analysis:
The global nasal spray market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the examples for these strategies are: In October 2016, Adapt Pharma received Health Canada approval for its naloxone hydrochloride nasal spray which is used for the treatment of opioid overdose. The report includes company share data for different geographies including Global, North America, Europe and APAC.
Key Companies Mentioned:
Some of the major players operating in this market are:
- Sandoz International
- Catalent
- Pfizer
- AptarGroup, Inc.
- Nastech pharmaceutical
- Adapt Pharma, Inc.
- Mylan N.V
- Innovus pharmaceuticals
- Allergan PLC
- Nephron pharmaceutical corporation
- Cipla ltd
- Meda pharmaceuticals, Inc.
- Sunovion pharmaceuticals
- Teva respiratory, Llc.
- Apotexcorp
- Novartis
- Valent pharmaceuticals international, Inc. among others.
Have Any Query? Ask Ours Expert @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-nasal-spray-market
Major Drivers:
Factors which may drive the growth of the nasal spray include increasing cases of allergic rhinitis and infections, changing lifestyle of people, rising level of pollution, increasing research and development of generic nasal spray drugs, rising awareness among the people, better alternate for other mode of drug delivery, painless,rising demand for self-administration, improving patient compliance, increasing acceptability, and more effective as compared to other forms. It is found that allergic rhinitis affects 10 to 30% of children and adults in the U.S. and other industrialized countries. Prevalence of allergic rhinitis is countries such as Australia, New Zealand and the United Kingdom.On the other hand, addiction to nasal sprays, temporary relief, pungent smell, sneezing, nasal irritation, runny nose, bleeding from nose, and regulatory reforms are some of the major factors which may restraints the growth of nasal spray market.
Report Segmentation:
The market is segmented on the basis of product type, container design, dosage form, prescription/availability, therapeutic class, application, and end-user. On the basis of product type the global nasal spray market is segmented into decongestion nasal spray, salt water solution/ saline nasal spray, and steroid nasal spray. On the basis of end-user the global nasal spray market is segmented into hospitals, clinics, home care settings, pharmacies, and community health care.
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. In 2017, North America is expected to dominate the nasal spray market with 52.1% market share followed by Europe and APAC.
Read more about the Global Nasal Spray Market Visit @ http://databridgemarketresearch.com/reports/global-nasal-spray-market/
Table of Contents:
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
5. NASAL SPRAY MARKET, BY PRODUCT TYPE
6. NASAL SPRAY MARKET, BY CONTAINER DESIGN
7. NASAL SPRAY MARKET, BY DOSAGE FORM
8. NASAL SPRAY MARKET, BY PRESCRIPTION/AVAILABILITY
9. NASAL SPRAY MARKET, BY THERAPEUTIC CLASS
10. NASAL SPRAY MARKET, BY APPLICATION
11. NASAL SPRAY MARKET, BY END USER
12. NASAL SPRAY MARKET, BY GEOGRAPHY
13. NASAL SPRAY MARKET: COMPETITIVE LANDSCAPE
14. NASAL SPRAY MARKET, COMPANY PROFILES
15. APPENDIX
About Data Bridge Market Research
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Nasal Spray Market Trends and Opportunities by Prescription, Container Design, Therapeutic Class, Types and Application in Grooming Regions; Global Edition 2018-2024
Data Bridge Market Research released a new research report of 350 pages on title “Nasal Spray Market Trends and Opportunities By Prescription, Container Design, Therapeutic Class, Types And Application In Grooming Regions; Global Edition 2018-2024” with detailed analysis, forecast and strategies.